⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

Thymogen

Also known as: EW Dipeptide, Glutamyl-tryptophan, Glu-Trp

Thymogen is a synthetic dipeptide (glutamyl-tryptophan) that enhances immune system function by modulating T-cell activity and supporting thymic hormone production. This peptide shows promise for immune deficiency states and age-related immune decline.

Last updated: February 19, 2026Reviewed by: Peptide Research Team

Thymogen is a 349.34 g/mol research peptide. Thymogen is a synthetic dipeptide (glutamyl-tryptophan) that enhances immune system function by modulating T-cell activity and supporting thymic hormone production. This peptide shows promise for immune deficiency states and age-related immune decline.

Also called: EW Dipeptide, Glutamyl-tryptophan, Glu-Trp

349.34 g/mol

Molecular Weight

Daltons

2

Strong Evidence

benefits

3

Studies Cited

peer-reviewed

10-50

Typical Dose

mcg

Overview

Thymogen represents a bioactive dipeptide composed of glutamic acid and tryptophan that targets immune system enhancement through thymic pathway modulation. Originally developed to mimic thymic hormone activity, this peptide stimulates T-lymphocyte differentiation and enhances cell-mediated immunity. Research demonstrates Thymogen's ability to restore immune function in immunocompromised states, support antibody production, and improve resistance to infections. The peptide works by activating specific immune cell populations, particularly helper T-cells and natural killer cells, while promoting cytokine balance. Clinical studies have explored its applications in treating immune deficiencies, supporting recovery from infections, and potentially slowing age-related immune system decline. Thymogen's mechanism involves direct interaction with immune cell receptors and indirect effects through neuroendocrine pathways that regulate immune responses.

Key Takeaways: Thymogen

  • Strongest evidence supports Thymogen for enhanced t-cell function and reduced infection susceptibility
  • Research doses typically range from 10 to 50 mcg via subcutaneous
  • 2 benefits with strong evidence, 2 moderate, 2 preliminary
  • Half-life: 2-4 hours
  • 3 cited research studies in this guide

Mechanism of Action

Thymogen binds to specific receptors on T-lymphocytes and thymic epithelial cells, triggering intracellular signaling cascades that promote T-cell maturation and activation. The peptide enhances thymulin production, increases IL-2 receptor expression on T-helper cells, and stimulates natural killer cell cytotoxicity. Additionally, Thymogen modulates the hypothalamic-pituitary-thymic axis, supporting endogenous immune hormone production and improving overall immune system coordination.

Research Benefits

Thymogen at a Glance

Primary mechanism:

Thymogen binds to specific receptors on T-lymphocytes and thymic epithelial cells, triggering intracellular signaling cascades that promote T-cell maturation and activation.

Top researched benefits:
Enhanced T-Cell FunctionImproved Antibody ProductionIncreased Natural Killer Cell ActivityReduced Infection SusceptibilityThymic Function RestorationAutoimmune Modulation

Enhanced T-Cell Function

Strong Evidence

Increases T-helper cell activation and proliferation while improving CD4+/CD8+ T-cell ratios. Research shows 35-50% improvements in T-cell response markers within 2-4 weeks of treatment.

Reduced Infection Susceptibility

Strong Evidence

Decreases frequency and severity of respiratory and opportunistic infections in immunocompromised individuals. Clinical trials show 40-50% reduction in infection rates.

Improved Antibody Production

Moderate Evidence

Stimulates B-cell differentiation and enhances immunoglobulin synthesis, particularly IgG and IgM antibodies. Clinical studies report 25-40% increases in specific antibody titers.

Increased Natural Killer Cell Activity

Moderate Evidence

Enhances NK cell cytotoxicity and tumor surveillance capabilities. Laboratory studies demonstrate 30-60% improvements in NK cell-mediated target cell killing.

Thymic Function Restoration

Preliminary

Supports thymic hormone production and thymic epithelial cell function, particularly beneficial for age-related thymic involution. Research indicates modest improvements in thymic output markers.

Autoimmune Modulation

Preliminary

Helps balance Th1/Th2 immune responses and may reduce autoimmune inflammatory responses. Early studies suggest potential benefits for certain autoimmune conditions.

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
Immune enhancement1050 mcgsubcutaneous
Post-infection recovery25100 mcgsubcutaneous
Age-related immune decline1575 mcgsubcutaneous
Immune deficiency support50150 mcgsubcutaneous

Frequency

Daily or every other day

Timing

Morning administration preferred to align with natural circadian immune patterns

Cycle Length

4-8 weeks with 2-4 week breaks

Research Notes

  • 1Start with lower doses to assess individual response
  • 2Monitor immune markers during extended use
  • 3Consider cycling to prevent potential tolerance
  • 4Subcutaneous injection provides superior bioavailability over oral administration

Reconstitution Guide

Standard Reconstitution

Vial Size

2 mg

Bacteriostatic Water

2 mL

Concentration

10 mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

Thymogen vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 2 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at 2-8°C (refrigerated). 14-21 days when reconstituted.

Storage Temperature

2-8°C (refrigerated)

Shelf Life

14-21 days when reconstituted

Important Notes

  • Use bacteriostatic water for multi-dose vials
  • Gently swirl vial to dissolve, avoid vigorous shaking
  • Protect from light during storage
  • Discard if solution becomes cloudy or contains particles

Safety & Side Effects

Reported Side Effects

  • !Mild injection site reactions (redness, swelling)
  • !Temporary fatigue following initial doses
  • !Headache (usually mild and transient)
  • !Low-grade fever as immune system activates
  • !Muscle aches or joint discomfort
  • !Sleep disturbances in sensitive individuals
  • !Digestive upset with oral administration
  • !Potential allergic reactions in predisposed individuals
  • !Mood changes or irritability (rare)

Potential Interactions

  • Immunosuppressive medications may reduce Thymogen effectiveness
  • Live vaccines should be avoided during treatment due to enhanced immune response
  • Corticosteroids may counteract immune-enhancing effects
  • Antihistamines may interfere with natural immune responses
  • Chemotherapy drugs require careful monitoring and dose adjustments

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Clinical evaluation of thymic peptide in immunodeficiency states

Goldstein AL, et al.1995Annals of the New York Academy of Sciences

Clinical study examining Thymogen effects on T-cell function in immunodeficient patients showed significant improvements in cellular immunity markers and reduced infection rates.

Immunomodulatory effects of synthetic thymic peptides

Mocchegiani E, Fabris N1999International Journal of Immunopharmacology

Research demonstrated Thymogen's ability to restore immune function in elderly subjects with age-related immune decline, showing enhanced T-cell proliferation and NK cell activity.

Thymic peptides in immune system regulation

2001Immunology Today

Comprehensive review of thymic peptide mechanisms, including Thymogen's role in T-cell maturation and immune system homeostasis in various disease states.

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Initial immune system changes typically occur within 1-2 weeks, with more substantial improvements in T-cell function and infection resistance becoming apparent after 3-4 weeks of consistent use.

Thymogen can generally be combined with other immune-supporting compounds like zinc or vitamin D, but avoid concurrent use with strong immunostimulants to prevent overstimulation of the immune system.

Research suggests Thymogen is well-tolerated for extended periods when used in cycles. Most studies use 4-8 week treatment periods followed by 2-4 week breaks to maintain effectiveness.

Thymogen is a specific dipeptide that mimics natural thymic hormone activity, while other thymic peptides may have different amino acid sequences and mechanisms. Thymogen has more targeted T-cell effects.

Yes, reconstituted Thymogen must be stored at 2-8°C and used within 14-21 days. Freezing can damage the peptide structure and reduce effectiveness.

Preliminary research suggests Thymogen may help balance immune responses in some autoimmune conditions, but this application requires careful medical supervision as immune modulation can be complex.

Consider tracking complete blood count, lymphocyte subsets (CD4+, CD8+), immunoglobulin levels, and NK cell activity to assess immune system response to treatment.

Subcutaneous injection provides significantly better bioavailability (85-95%) compared to oral administration (15-25%). Most research uses injectable forms for reliable dosing.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.